Arrowhead Lead Scientific Advisor, Dr. Mauro Ferrari and Calando Pharmaceuticals’ siRNA Drug Delivery Platform …
May 27, 2010 by AboutNanoWires.com · Leave a Comment
Arrowhead Lead Scientific Advisor, Dr. Mauro Ferrari and Calando Pharmaceuticals’ siRNA Drug Delivery Platform …
Arrowhead Research Corporation (NASDAQ:ARWR) today announced that two articles of interest to Arrowhead stockholders appeared in the Houston Chronicle this week. An article published on May 24, entitled “Minute invaders that aid the body”, reports on the revolutionary potential of gene silencing and the pioneering role of the siRNA delivery system developed by Arrowhead majority-owned subsidiary …
Read more on SYS-CON Media
Abstract about Phase I/II trial of ThermoDox in RCW accepted for presentation at ASCO 2010
March 25, 2010 by AboutNanoWires.com · Leave a Comment
Abstract about Phase I/II trial of ThermoDox in RCW accepted for presentation at ASCO 2010
Celsion Corporation today announced that an abstract about the Phase I/II trial of ThermoDox® in Recurrent Chest Wall Cancer (RCW) has been accepted for presentation at the American Society of Clinical Oncology 2010 Annual Meeting.
Read more on News-Medical-Net
